Pharma's Almanac

RNA Editing

Rewriting the Script: The Past, Present, and Future of RNA Editing Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

Protein Design

Reprogramming the Rules: How AI Is Transforming De Novo Protein Design in Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

AI and Gender

The Gender Bias Built Into AI — And Its Threat to Women’s Health

David Alvaro, Ph.D.

Pharma's Almanac

Gene Therapy

Gene Therapy at 30: Milestones, Setbacks, and a Path Forward

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Trans and Non-Binary

Beyond the Binary: Including Trans and Non-Binary Individuals in Clinical Research

David Alvaro, Ph.D.

Pharma's Almanac

First-in-Class Drugs

Breaking New Ground: 30 Years of First-in-Class Drug Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Maternal Health

Maternal Mandate: Elevating Innovation, Equity, and Investment in Women’s Health

David Alvaro, Ph.D.

Pharma's Almanac

Spintronics

Spintronics and the Future of Drug Design

David Alvaro, Ph.D.

Pharma's Almanac

DNA Nanobots

DNA Nanobots: Precision Machines at the Molecular Frontier

David Alvaro, Ph.D.

Pharma's Almanac

Biotechs

Five Small Biotechs to Watch: April 2025

David Alvaro, Ph.D.

Pharma's Almanac

Supply Chain

Building Resilient Pharma Supply Chains in an Uncertain World

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Cell Therapy

Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights

April Stanley, MS MBA; Sophie Lutter, Ph.D.

Nice Insight

RNA

Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate

Cynthia A. Challener, Ph.D.; April Stanley, MS MBA

Pharma's Almanac

Drug Approvals

How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?

Pharma's Almanac

RNA

What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?

Pharma's Almanac

NIH

The White House’s War on the NIH and the Disasters Ahead

David Alvaro, Ph.D.

Pharma's Almanac

SUT

From Niche to Necessity: How Single-Use Transformed Biomanufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

RNA

Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

Genomics

Genomics and the Next Era of Precision Medicine

David Alvaro, Ph.D.

Pharma's Almanac

Aging

Resetting the Biological Clock: OKSM and the Reversal of Aging

David Alvaro, Ph.D.

Pharma's Almanac